Reply to "Myelin Oligodendrocyte Glycoprotein Antibody-Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions"

Ann Neurol. 2024 Feb;95(2):415-416. doi: 10.1002/ana.26856. Epub 2023 Dec 23.

Authors

Javier Villacieros-Álvarez^{1

2}, Carmen Espejo^{1

2}, Álvaro Cobo-Calvo^{1

2}

Affiliations

¹ Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Research Institute, Barcelona, Spain.
² Autonomous University of Barcelona, Barcelona, Spain.

PMID: 38081749
DOI: 10.1002/ana.26856

No abstract available

Publication types

Letter

MeSH terms

Autoantibodies
Brain
Humans
Multiple Sclerosis* / diagnosis
Multiple Sclerosis* / therapy
Myelin-Oligodendrocyte Glycoprotein

Substances

Myelin-Oligodendrocyte Glycoprotein
Autoantibodies